StockData
Nasus Pharma Ltd logo

Nasus Pharma Ltd (NSRX) shareholders

NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 25, 2026Score 6/30
$2.61−0.05 (-1.88%)

Close on Nov 17, 2026Market cap $23.53MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
23.9%
2M of 9M shares
Institutional holders
10
4 new, 3 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
3 buys · 0 sales
Net bought $61.81K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Udi Gilboa1,901,31121.10%13G (passive)Sep 30, 2025
Dr. Dalia Megiddo1,888,87320.90%13G (passive)Sep 30, 2025
Dr. Ronnie Hershman
Joint filing with Hershman Holdings LLC (9.90%)
1,383,51215.30%13G (passive)Sep 30, 2025
Dames GP LLC
Joint filing with Balyasny Asset Management L.P. (9.99%), Bam Gp LLC (9.99%) and 2 more
1,169,9109.99%13G (passive)Mar 31, 2026
Balyasny Asset Management L.P.
Joint filing with Bam Gp LLC (9.99%), Balyasny Asset Management Holdings LP (9.99%) and 2 more
1,169,9099.99%13G (passive) amendmentJun 30, 2026
Ma-Weaver Jacob
Joint filing with Funicular Funds, LP (5.20%), Cable Car Capital, LP (5.20%)
612,9135.20%13G (passive)Mar 31, 2026
Capital Point Ltd.575,1296.35%13G (passive)Aug 14, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of NSRXValueChange% of portfolio
Balyasny Asset Management L.P.898,4739.97%$3.14M–0.00%
Cable Car Capital, LP616,0816.83%$2.16M+14,0830.05%
Velan Capital Investment Management LP359,3903.99%$1.26M–0.77%
Hudson Bay Capital Management LP134,7711.49%$471.70K–0.00%
Bleichroeder LP89,8481.00%$314.47K–0.06%
Citadel Advisors LLC22,0040.24%$77.01KNew0.00%
XTX Topco Ltd16,6400.18%$58.24KNew0.00%
Renaissance Technologies LLC12,2000.14%$42.70KNew0.00%
Morgan Stanley1,0000.01%$3.50K−1,0000.00%
Caitong International Asset Management Co., Ltd40.00%$14New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026102M23.9%4 / 11 / 30M0M
Q1 202692M24.1%7 / 10 / 02M0M
Q4 202520M0.0%0 / 01 / 00M0M
Q3 202520M0.0%2 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Brendan P. O'GradyChief Executive Officer, Director––Nov 13, 2026
Dan Benjamin TelemanChief Executive Officer, Director163,5411.81%Jul 29, 2026
Dalia MegiddoChief Development Officer, Director1,894,06821.01%Mar 27, 2026
Oren ElmaliahInterim CFO––Nov 16, 2026
Eyal RubinChief Financial Officer––Sep 21, 2026
Sharon ShachamDirector––Mar 27, 2026
David SilbermanDirector––Mar 27, 2026
Isaac IsraelDirector––Mar 27, 2026
Ronnie HershmanDirector1,338,46314.85%Mar 27, 2026
Udi Gilboa–1,924,47621.35%Mar 27, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Dan Benjamin Teleman
Chief Executive Officer, Director
Jun 17, 2026Buy+6,550$3.10$20.31K163,541
Dan Benjamin Teleman
Chief Executive Officer, Director
Apr 22, 2026Buy+2,900$3.76$10.90K156,991
Dan Benjamin Teleman
Chief Executive Officer, Director
Mar 31, 2026Buy+15,000$2.04$30.60K21,246

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
1.93%
0M shares short
Days to cover
3.6
At 0M shares a day
Change since last report
-11.7%
From 0M shares
Short volume, 20 days
48.5%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Nasus Pharma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 4,351 shares on Oct 5, 2026 over the last 90 days.

See a number that looks wrong?